Related Experiment Video
Updated: May 2, 2026

08:01
Biobank for Translational Medicine: Standard Operating Procedures for Optimal Sample Management
Published on: November 30, 2022
7.3K
p-BioSPRE-an information and communication technology framework for transnational biomaterial sharing and access
Gabriele Weiler1, Christina Schröder2, Fatima Schera1
1Fraunhofer Institute for Biomedical Engineering IBMT, Ensheimer Strasse 48, 66386 St. Ingbert, Germany.
Ecancermedicalscience
|February 26, 2014
Summary
Biobanks are crucial for personalized medicine research. The p-BioSPRE framework facilitates secure access and sharing of biospecimens and data, supporting clinico-genomic studies.
Area of Science:
- Biomedical Informatics
- Genomics
- Biobanking
Background:
- Biobanks are essential for clinico-genomic research and personalized medicine.
- Secure access and sharing of high-quality biomaterial and data are critical for scientific advancement.
- Integrating biobanks into biomedical Information and Communication Technology (ICT) infrastructures is a growing area of interest.
Purpose of the Study:
- To describe the p-BioSPRE framework, a component of the European p-medicine project.
- To enable secure access to and sharing of biobank resources for personalized medicine research.
- To simplify the management of biospecimens and related clinical data.
Main Methods:
- Development of the p-BioSPRE (p-medicine Biospecimen Search and Project Request Engine) framework.
- Integration with the ObTiMA Trial Biomaterial Manager for data management.
- Consideration of ethical and legal standards for data and biospecimen sharing.
Main Results:
- p-BioSPRE provides a generic framework for accessing existing biobanks and offering biomaterial collections.
- The framework ensures secure sharing of biospecimens and data within research communities.
- It supports flexible integration of clinical and omics data, with initial applications in cancer research (leukemia, Wilms tumor).
Conclusions:
- The p-BioSPRE framework enhances secure and efficient access to biobank resources for personalized medicine.
- It addresses ethical and legal considerations, empowering biobanks to maintain control.
- The framework is adaptable for various disease entities beyond the initial cancer focus.
Related Concept Videos
Issues And Trends In Healthcare Delivery System
6.5K
The issues and trends in healthcare delivery are constantly changing. The COVID-19 pandemic is one recent issue that wreaked havoc on healthcare systems, causing a shortage of healthcare workers, high demand for medicines and supplies, and increased medical expenditure due to a lack of insurance. Other issues include rising healthcare costs and care fragmentation.
Cost Containment
Payment for healthcare services has historically promoted adoption of costly and often unnecessary or inefficient...
Cost Containment
Payment for healthcare services has historically promoted adoption of costly and often unnecessary or inefficient...
6.5K
Drug Products: Biologics, Biosimilars and Interchangeables
369
Biologics, derived from living sources such as humans, animals, or microorganisms, represent a significant category of pharmaceuticals. These complex molecules, developed through advanced biotechnological methods or purified from natural sources, include essential medical treatments like insulin and growth hormones. The complexity of biologics arises from their large molecular structures and the intricate processes required for their production, making them distinct from conventional...
369
Biofilms
2.1K
Biofilms are complex communities of microorganisms encased in a self-produced extracellular polysaccharide matrix attached to surfaces. These microbial consortia can include single or multiple species, providing enhanced survival benefits by forming organized, multilayered structures.The formation of biofilms occurs through four key stages: attachment, colonization, development, and dispersal.During attachment, free-swimming planktonic cells adhere to a surface, often facilitated by...
2.1K
Upstream Processing
97
Upstream processing represents a critical phase in biomanufacturing, wherein biological systems such as microorganisms, mammalian cells, or insect cells are cultivated to produce therapeutic proteins, vaccines, enzymes, or other biologically derived products. This phase encompasses all steps from the selection and genetic manipulation of the production organism to the cultivation of cells in bioreactors under tightly controlled environmental conditions.Host Selection and Genetic OptimizationThe...
97

